04/16/2024
3:12 PM | Teva Pharmaceutical Industries (Filer)
| Form ARS | |
04/16/2024
3:16 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A | |
04/09/2024
9:26 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
03/07/2024
3:27 PM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:57 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:48 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/01/2024
5:52 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:54 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:40 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:43 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:45 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:37 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
6:42 AM | Francis Richard D (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
6:37 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2024
6:49 AM | Teva Pharmaceutical Industries (Issuer)
Weiss Amir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
7:03 AM | Phoenix Holdings Ltd. (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G | |
02/01/2024
6:26 AM | Kalif Eliyahu Sharon (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:28 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:18 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
6:22 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
6:18 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:17 AM | Fox Christine (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/16/2023
6:35 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
6:36 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
6:15 AM | Bergwerk Dov (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/05/2023
6:20 AM | Conway Vikki L (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2023
5:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:05 PM | Shalev Varda (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
6:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:09 AM | Hughes Eric A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2023
3:06 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
6:34 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:35 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:36 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:37 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:38 AM | Teva Pharmaceutical Industries (Issuer)
Vergis Janet S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
06/20/2023
6:39 AM | Teva Pharmaceutical Industries (Issuer)
Zaks Tal Zvi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:31 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:32 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
6:33 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
11:32 AM | Capital Research Global Investors (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A | |
06/08/2023
7:30 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
6:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
